The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function
PLoS ONE - United States
doi 10.1371/journal.pone.0039163
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 13, 2012
Authors
Publisher
Public Library of Science (PLoS)